Latest news
Maplight Therapeutics (NASDAQ:MPLT) Shares Down 6.4% - Time to Sell? - MarketBeatMarketBeat · Fri, 07 Aug 2026 16:50:32 GMTBronstein, Gewirtz & Grossman, LLC Is Investigating MapLight Therapeutics, Inc. (MPLT) And Encourages Investors to Connect - ACCESS NewswireACCESS Newswire · Fri, 07 Aug 2026 08:03:41 GMTMaplight Therapeutics (NASDAQ:MPLT) Insider Sells 22,082 Shares of Stock - MarketBeatMarketBeat · Wed, 05 Aug 2026 01:59:10 GMTMPLT Investors Have Opportunity to Join MapLight Therapeutics, Inc. Fraud Investigation with SBS Law - TradingViewTradingView · Mon, 03 Aug 2026 06:22:00 GMTMPLT: MapLight Therapeutics, Inc. - Balance Sheet - Zacks Investment ResearchZacks Investment Research · Sun, 02 Aug 2026 18:03:58 GMTMapLight Therapeutics, Inc. (MPLT) stock price, news, quote and history - Yahoo Finance UKYahoo Finance UK · Sun, 02 Aug 2026 11:22:45 GMTMaplight Therapeutics (NASDAQ:MPLT) Rating Lowered to Strong Sell at Wall Street Zen - MarketBeatMarketBeat · Sat, 01 Aug 2026 06:23:45 GMTMaplight Therapeutics (NASDAQ:MPLT) Shares Down 9.2% - What's Next? - MarketBeatMarketBeat · Thu, 30 Jul 2026 19:04:58 GMT